ECT2 peptides and vaccines including the same

Details for Australian Patent Application No. 2011233401 (hide)

Owner Oncotherapy Science, Inc.

Inventors Nakamura, Yusuke; Tsunoda, Takuya; Ohsawa, Ryuji; Yoshimura, Sachiko; Watanabe, Tomohisa

Agent Davies Collison Cave

Pub. Number AU-A-2011233401

PCT Pub. Number WO2011/122022

Priority 61/320,577 02.04.10 US

Filing date 30 March 2011

Wipo publication date 6 October 2011

International Classifications

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

25 October 2012 PCT application entered the National Phase

  PCT publication WO2011/122022 Priority application(s): WO2011/122022

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011233415-Composite structure, packaging material and molded article each produced using same, process for production of composite structure, and coating solution

2011233363-O/W emulsion composition